Literature DB >> 3607040

Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells.

J M Davis, T Arakawa, T W Strickland, D A Yphantis.   

Abstract

Physicochemical properties of recombinant human erythropoietin were examined. This protein, produced in Chinese hamster ovary cells, showed a conformation apparently identical with the natural product isolated from human urine when examined by circular dichroism, UV absorbance, and fluorescence spectroscopy. Sedimentation equilibrium experiments showed the recombinant erythropoietin preparation to be essentially a single macromolecular component with a molecular weight of 30,400 and a carbohydrate content of 39%. The Stokes radius of recombinant erythropoietin was estimated to be 32 A from gel filtration, much larger than the 20-A radius calculated for a sphere of the observed molecular weight. This difference may be ascribed to the extensive glycosylation. The fluorescence and phosphorescence spectra showed that the luminescent tryptophan(s) is (are) solvent-exposed and can be quenched by I- and acrylamide but not by Cs+. On acid titration, the recombinant erythropoietin showed a conformational transition with a midpoint of pH 4.1. This suggests that the net charges on the protein moiety rather than on the whole molecule play a role in protein structure stability.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3607040     DOI: 10.1021/bi00383a034

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  Expression of recombinant erythropoietin in stably transformed Drosophila melanogaster S2 cells.

Authors:  J M Lee; J H Park; J O Park; K H Chang; I S Chung
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

2.  Production of recombinant proteins in serum-free media.

Authors:  D Broad; R Boraston; M Rhodes
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

3.  Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells.

Authors:  M Takeuchi; N Inoue; T W Strickland; M Kubota; M Wada; R Shimizu; S Hoshi; H Kozutsumi; S Takasaki; A Kobata
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Nonspecific shielding of unfavorable electrostatic intramolecular interactions in the erythropoietin native-state increase conformational stability and limit non-native aggregation.

Authors:  Douglas D Banks
Journal:  Protein Sci       Date:  2015-04-11       Impact factor: 6.725

5.  Erythropoietin: the developing story.

Authors:  P M Cotes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-19

6.  Convergent chemical synthesis of [lysine(24,38,83)] human erythropoietin.

Authors:  Suhuai Liu; Brad L Pentelute; Stephen B H Kent
Journal:  Angew Chem Int Ed Engl       Date:  2011-12-16       Impact factor: 15.336

7.  Pharmacokinetic and pharmacodynamic profiles of recombinant human erythropoietin-loaded poly(lactic-co-glycolic acid) microspheres in rats.

Authors:  Xiang-lian Zhou; Jin-tian He; Hui-juan Du; Yang-yang Fan; Ying Wang; Hong-xia Zhang; Yang Jiang
Journal:  Acta Pharmacol Sin       Date:  2011-12-05       Impact factor: 6.150

8.  Pharmacodynamic analysis of stress erythropoiesis: change in erythropoietin receptor pool size following double phlebotomies in sheep.

Authors:  Mohammad I Saleh; John A Widness; Peter Veng-Pedersen
Journal:  Biopharm Drug Dispos       Date:  2011-01-10       Impact factor: 1.627

9.  Pharmacokinetics of epoetin (recombinant human erythropoietin) after long term therapy in patients undergoing haemodialysis and haemofiltration.

Authors:  U Gladziwa; U Klotz; K Bäumer; R Zollinger; H Mann; H G Sieberth
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

Review 10.  State-of-the-art biosimilar erythropoietins in the management of renal anemia: lessons learned from Europe and implications for US nephrologists.

Authors:  Adrian Covic; Ivo Abraham
Journal:  Int Urol Nephrol       Date:  2015-07-30       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.